GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nanosphere Health Sciences Inc (OTCPK:NSHSF) » Definitions » 3-Year FCF Growth Rate

NSHSF (Nanosphere Health Sciences) 3-Year FCF Growth Rate : 14.00% (As of Sep. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Nanosphere Health Sciences 3-Year FCF Growth Rate?

Nanosphere Health Sciences's Free Cash Flow per Share for the three months ended in Sep. 2024 was $-0.01.

During the past 3 years, the average Free Cash Flow per Share Growth Rate was 14.00% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 63.10% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 51.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Nanosphere Health Sciences was 88.20% per year. The lowest was -92.40% per year. And the median was 68.10% per year.


Competitive Comparison of Nanosphere Health Sciences's 3-Year FCF Growth Rate

For the Biotechnology subindustry, Nanosphere Health Sciences's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nanosphere Health Sciences's 3-Year FCF Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Nanosphere Health Sciences's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Nanosphere Health Sciences's 3-Year FCF Growth Rate falls into.



Nanosphere Health Sciences 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Nanosphere Health Sciences  (OTCPK:NSHSF) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Nanosphere Health Sciences 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Nanosphere Health Sciences's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Nanosphere Health Sciences Business Description

Traded in Other Exchanges
Address
1090 West Georgia Street, Suite 488, Vancouver, BC, CAN, V6E 3V7
Nanosphere Health Sciences Inc is a nano-biotechnology company. The company is focused on providing next-generation delivery of nutritive elements and medications. Its NanoSphere Delivery System platform technology addresses the problems of low bioavailability and excessive dosage amounts of a wide range of bioactive compounds. It focuses on developing nanoencapsulation technology for the delivery of nutritive elements and medicants through licensing arrangements.